Related Experiment Video
Updated: Mar 21, 2026
09:39
Creation of Reversible Cholestatic Rat Model
Published on: May 21, 2011
15.5K
Recent advances in understanding and managing cholestasis.
Martin Wagner1, Michael Trauner2
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
F1000Research
|May 3, 2016
Summary
Cholestatic liver diseases impair bile acid circulation. Targeting key regulators like farnesoid X receptor offers new therapeutic strategies for these liver conditions.
Area of Science:
- Hepatology
- Molecular Biology
- Pharmacology
Background:
- Cholestatic liver diseases involve impaired bile acid excretion and enterohepatic circulation.
- Pathological mechanisms, especially for acquired forms, require further elucidation.
- Understanding bile acid circulation is key to developing targeted therapies.
Purpose of the Study:
- To review the central roles of key molecular regulators in bile acid enterohepatic circulation.
- To highlight the potential of these regulators as novel drug targets for cholestatic liver diseases.
Main Methods:
- Literature review focusing on molecular mechanisms of bile acid transport.
- Analysis of the roles of farnesoid X receptor, fibroblast growth factor 19, and apical sodium-dependent bile acid transporter.
- Discussion of pharmacological targeting strategies.
Main Results:
- Farnesoid X receptor, fibroblast growth factor 19, and apical sodium-dependent bile acid transporter are central to bile acid enterohepatic circulation.
- These molecules represent promising targets for therapeutic intervention in cholestasis.
- Advances in understanding molecular mechanisms reveal common pathways for drug development.
Conclusions:
- Targeting farnesoid X receptor, fibroblast growth factor 19, and apical sodium-dependent bile acid transporter holds significant therapeutic potential for cholestatic liver diseases.
- Further research into these pathways can lead to effective treatments for impaired bile acid metabolism.
- Pharmacological targeting of these mechanisms offers a promising avenue for managing liver cholestasis.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
467
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
467
01:30Acute Pancreatitis II: Clinical Manifestations and Management
1.0K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.0K
01:24Chronic Pancreatitis I: Introduction
858
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
858
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
249
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
249
01:28Esophageal Varices-II: Clinical Features and Management
736
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
736
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
331
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
331